Evaluating the Efficacy and Safety of Two Doses of the Polyclonal Anti-Tumor Necrosis Factor-α Fragment Antibody AZD9773 in Adult Patients With Severe Sepsis and/or Septic Shock

Gordon R. Bernard, Xavier Wittebole, Pierre‐François Laterre et al.|Critical Care Medicine|2013

Cited by 85